Geritrex Recalls Carb-O-Philic 40 Cream Due to Container Closure Deviation
Geritrex Corp is recalling Carb-O-Philic 40 Cream due to a CGMP deviation involving poor container closure of the bulk storage container.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Geritrex Corp is recalling Carb-O-Philic 40 Cream, 40%, in 3 oz. and 7 oz. tubes. The recall is due to a Current Good Manufacturing Practice (CGMP) deviation identified as poor container closure of the bulk storage container.
The affected products are Carb-O-Philic 40 Cream, 40%, manufactured by Geritrex Corporation in Mount Vernon, NY. The recall includes 1,488 tubes, consisting of 1,008 3 oz. tubes and 480 7 oz. tubes. The specific lots affected are Lot # 1502076 (Exp. 08/16) for the 3 oz. tubes, and Lot # 1502077 and 1503030 (Exp. 08/16) for the 7 oz. tubes. The products were distributed nationwide.
The FDA has classified this recall as Class III, which indicates that the product is not likely to cause adverse health consequences. Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If found, the products should be returned to the pharmacy or point of purchase for disposal or credit, in accordance with standard recall procedures.
The recalled product
- Product
- Carb-O-Philic 40 Cream, 40%, a) 3 oz. tube (NDC 54162-640-03) b) 7 oz. tube (NDC 54162-640-07), Rx Only, Manufactured by Geritrex Corporation, Mount Vernon, NY 10550
- Manufacturer
- Geritrex Corp
- Category
- Drug — Topical Cream
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- a) Lot # 1502076
- Exp. 08/16 b) Lot # 1502077
- 1503030
- Exp. 08/16
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Geritrex Corp
See all →- ModerateGeritrex Recalls Unapproved Carbo-O-Philic 40 Cream Tubes Nationwide
FDA (Drugs) · 2015-12-09
- ModerateGeritrex Recalls Unapproved Polyethylene Glycol 3350 Powder Jars
FDA (Drugs) · 2015-12-09
- SevereGeritrex Recalls Unapproved Hydrocortisone Suppositories Nationwide
FDA (Drugs) · 2015-12-09
- ModerateGeritrex Recalls Unapproved Carbo-O-Philic 40 Gel Topical Urea Product
FDA (Drugs) · 2015-12-09
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateGeritrex Recalls Unapproved Carbo-O-Philic 40 Cream Tubes Nationwide
FDA (Drugs) · 2015-12-09
- ModerateGeritrex Recalls Unapproved Carbo-O-Philic 40 Gel Topical Urea Product
FDA (Drugs) · 2015-12-09
- SevereGeritrex Recalls Ritussin DM Due to Potential Microbial Contamination
FDA (Drugs) · 2019-07-31
- ModerateGeritrex Recalls Unapproved Polyethylene Glycol 3350 Powder Jars
FDA (Drugs) · 2015-12-09
- SevereGericare Geri-Tussin DM Recalled for Potential Microbial Contamination
FDA (Drugs) · 2019-07-31
- SevereGeritrex Recalls Diphenhydramine Oral Liquid Due to Potential Microbial Contamination
FDA (Drugs) · 2019-07-31